212 results on '"Jehn, Ulrich"'
Search Results
2. Welche Rolle spielt das Geschlecht bei der Nierentransplantation?
3. Sparsentan versus Irbesartan bei fokal segmentaler Glomerulosklerose
4. Plasma protein signatures reflect systemic immunity and allograft function in kidney transplantation
5. Urinary Dickkopf 3 Is Not an Independent Risk Factor in a Cohort of Kidney Transplant Recipients and Living Donors
6. #2237 Preliminary results of Protection of Renal Function after Conversion of fast IR-Tac Metabolizers to Envarsus® study (The Protect RENvarsus study)
7. Unveiling systemic responses in kidney transplantation: interplay between the allograft transcriptome and serum proteins.
8. Hydroxychloroquine-Induced Renal Phospholipidosis: Case Report and Review of Differential Diagnoses
9. Higher cardiorespiratory fitness is strongly associated with lower cardiovascular risk factors in firefighters: a cross-sectional study in a German fire brigade
10. Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
11. Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation
12. Interactions with the CYP3A inhibitor voriconazole differ between extended-LCP- and immediate-release tacrolimus formulations
13. Tacrolimus—why pharmacokinetics matter in the clinic
14. Urinary dickkopf 3 in a kidney transplant and living donor cohort – independent risk factor or merely GFR-related?
15. Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation
16. An unusual case of ascites after kidney transplantation
17. Corrigendum: Novel Therapeutic Strategies for Dyslipidemia: First Report of Inclisiran Therapy in a Kidney Transplanted Patient
18. Novel Therapeutic Strategies for Dyslipidemia: First Report of Inclisiran Therapy in a Kidney Transplanted Patient
19. Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation
20. Cardiorespiratory Fitness Is Associated with a Reduced Cardiovascular Risk in Occupational Groups with Different Working Conditions: A Cross-Sectional Study among Police Officers and Office Workers
21. First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
22. First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
23. Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation
24. Metabolic Syndrome in Female Police Officers and Female Office Workers: A Cross-Sectional Study in Occupations with Different Physical Activities
25. Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
26. Belatacept as a Treatment Option in Patients with Severe BK Polyomavirus Infection and High Immunological Risk—Walking a Tightrope between Viral Control and Prevention of Rejection
27. MO1009: Early Switch from Fast IR-TAC Metabolizers to LCP-TAC Improves Renal Allograft Function
28. A Novel Homozygous Mutation in the COL4A4 Gene (Gly1436del) Causing Alport Syndrome Exposed by Pregnancy: A Case Report and Review of the Literature
29. Improved Kidney Allograft Function after Early Conversion of Fast IR-Tac Metabolizers to LCP-Tac
30. iPTH is not a significant factor influencing the tacrolimus C/D ratio
31. The Influence of Parathyroidectomy on Osteoporotic Fractures in Kidney Transplant Recipients: Results from a Retrospective Single-Center Trial
32. Requirements for Becoming an Adjunct Professor in Medicine: A Comparative Analysis of the Regulations of German Medical Faculties
33. Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation
34. α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes
35. Exercise capacity, cardiovascular and metabolic risk of the sample of German police officers in a descriptive international comparison
36. The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
37. Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation
38. Parathyroidectomy Protects Against Pathologic Fractures After Kidney Transplantation: Results From a Retrospective Single-center Trial
39. Cardiorespiratory Fitness Is Associated with a Reduced Cardiovascular Risk in Occupational Groups with Different Working Conditions: A Cross-Sectional Study among Police Officers and Office Workers
40. MO944BONE DISEASE AFTER KIDNEY TRANSPLANTATION - (SUBTOTAL) PARATHYROIDECTOMY REDUCES FRACTURE RISK
41. Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation
42. Metabolic Syndrome in Female Police Officers and Female Office Workers: A Cross-Sectional Study in Occupations with Different Physical Activities
43. Exercise capacity, cardiovascular and metabolic risk of the sample of German police officers in a descriptive international comparison
44. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) is a Risk Indicator for eGFR Loss in Kidney Transplant Recipients
45. Antihypertensive Treatment in Kidney Transplant Recipients—A Current Single Center Experience
46. Exercise capacity, Cardiovascular- and Metabolic Risk of German Police officers in an international comparison
47. Metabolic Syndrome in Female Police Officers and Female Office Workers: A Cross-Sectional Study in Occupations with Different Physical Activities
48. The Estimation Formula for the Urinary Albumin-Creatinine Ratio Based on the Protein-Creatinine Ratio Are Not Valid for a Kidney Transplant and a Living Donor Cohort
49. Prognostic Value of Growth Differentiation Factor 15 in Kidney Donors and Recipients
50. Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.